What is the brand name of Amiodarone? Select ALL That Apply.

A. Antiallergy medications generally include antihistamines or mast cell stabilizers that target the early-phase allergic response. While the corticosteroid component reduces inflammation, this combination is specifically indicated for chronic respiratory pathologies. It is not classified as a primary antiallergy agent.

B. Bronchoconstrictors represent a pharmacological class that narrow the airways, which is the opposite effect of this medication. Formoterol acts as a long-acting beta-2 agonist to induce smooth muscle relaxation. This drug combination is intended to treat, not cause, bronchoconstriction.

C. COPD agent is a correct classification as this combination is FDA-approved for the maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease. The long-acting bronchodilator ensures sustained patency of the airways. The corticosteroid component helps reduce the associated chronic inflammation.

D. Antiasthmatic is a correct therapeutic class because this combination targets the underlying inflammation and bronchoconstriction in asthma. Budesonide reduces airway hyperresponsiveness through glucocorticoid receptor activation. Formoterol provides long-acting bronchodilation to prevent nocturnal and exercise-induced symptoms.

A. Veramyst is a brand name for fluticasone furoate, not fluticasone propionate. Although both are corticosteroids, they differ in their salt forms and pharmacokinetic profiles. Veramyst was specifically marketed as a unique aqueous nasal spray formulation.

B. Advair is a combination product containing fluticasone propionate and salmeterol. It is administered via oral inhalation for asthma and chronic obstructive pulmonary disease. It is not the brand name for the monotherapy nasal spray formulation.

C. Flonase is the proprietary brand name for fluticasone propionate administered via the intranasal route. This glucocorticoid receptor agonist reduces inflammatory mediator release in the nasal mucosa. It is indicated for the management of seasonal and perennial allergic rhinitis.

D. Atrovent is the brand name for ipratropium bromide, which is an anticholinergic agent. It functions as a muscarinic antagonist to reduce secretions or induce bronchodilation. It does not contain a corticosteroid and is pharmacologically unrelated to fluticasone.